Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 4
1980 2
1981 1
1982 4
1983 4
1984 8
1985 13
1986 13
1987 19
1988 22
1989 74
1990 49
1991 56
1992 100
1993 111
1994 131
1995 145
1996 178
1997 215
1998 209
1999 243
2000 231
2001 254
2002 277
2003 318
2004 330
2005 280
2006 333
2007 321
2008 290
2009 256
2010 272
2011 249
2012 243
2013 242
2014 227
2015 251
2016 204
2017 183
2018 191
2019 163
2020 190
2021 183
2022 199
2023 49
Text availability
Article attribute
Article type
Publication date

Search Results

6,788 results
Results by year
Filters applied: . Clear all
Page 1
Paroxetine: a review.
Bourin M, Chue P, Guillon Y. Bourin M, et al. CNS Drug Rev. 2001 Spring;7(1):25-47. doi: 10.1111/j.1527-3458.2001.tb00189.x. CNS Drug Rev. 2001. PMID: 11420571 Free PMC article. Review.
Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently approved indications for the treatment of depression, obsessive-compulsive disorder, panic disorder and social phobia. ...Paroxetine exhibits some affinity for the muscarinic cho …
Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently approved indications for the treatment of dep …
Paroxetine-Overview of the Molecular Mechanisms of Action.
Kowalska M, Nowaczyk J, Fijałkowski Ł, Nowaczyk A. Kowalska M, et al. Int J Mol Sci. 2021 Feb 7;22(4):1662. doi: 10.3390/ijms22041662. Int J Mol Sci. 2021. PMID: 33562229 Free PMC article. Review.
The purpose of this review is to describe the interaction of paroxetine with several molecular targets in various points of view including the basic chemical and pharmaceutical properties. The central point of the review is focused on the pharmacodynamic analysis based on …
The purpose of this review is to describe the interaction of paroxetine with several molecular targets in various points of view incl …
Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis.
Carlson EL, Karuppagounder V, Pinamont WJ, Yoshioka NK, Ahmad A, Schott EM, Le Bleu HK, Zuscik MJ, Elbarbary RA, Kamal F. Carlson EL, et al. Sci Transl Med. 2021 Feb 10;13(580):eaau8491. doi: 10.1126/scitranslmed.aau8491. Sci Transl Med. 2021. PMID: 33568523
Thus, in a surgical OA mouse model, we performed genetic GRK2 deletion in chondrocytes or pharmacological inhibition with the repurposed U.S. Food and Drug Administration (FDA)-approved antidepressant paroxetine. ...Supporting experiments with cultured human OA cart …
Thus, in a surgical OA mouse model, we performed genetic GRK2 deletion in chondrocytes or pharmacological inhibition with the repurposed U. …
Paroxetine hydrochloride.
Germann D, Ma G, Han F, Tikhomirova A. Germann D, et al. Profiles Drug Subst Excip Relat Methodol. 2013;38:367-406. doi: 10.1016/B978-0-12-407691-4.00008-3. Profiles Drug Subst Excip Relat Methodol. 2013. PMID: 23668408 Review.
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotoni …
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-( …
Comparison of Dapoxetine /Tadalafil and Paroxetine/Tadalafil Combination Therapies for the Treatment of the Premature Ejaculation: A Randomized Clinical Trial.
Mohseni Rad H, Zahirian Moghadam T, Hosseinkhani A, Nima Soluki N, Amani F. Mohseni Rad H, et al. Urol J. 2021 Nov 13;19(2):138-143. doi: 10.22037/uj.v18i.6644. Urol J. 2021. PMID: 34773634 Free article. Clinical Trial.
PURPOSE: The purpose of this study was to compare the effectiveness of Dapoxetine, and Paroxetine as well as Dapoxetine/Tadalafil and Paroxetine/Tadalafil combinational therapies, for the treatment of patients with premature ejaculation. MATERIALS AND METHODS: In th …
PURPOSE: The purpose of this study was to compare the effectiveness of Dapoxetine, and Paroxetine as well as Dapoxetine/Tadalafil and …
Paroxetine: Into Oblivion?
Naguy A. Naguy A. Prim Care Companion CNS Disord. 2018 Jan 11;20(1):17l02113. doi: 10.4088/PCC.17l02113. Prim Care Companion CNS Disord. 2018. PMID: 29381271 Free article. No abstract available.
A review of paroxetine for the treatment of vasomotor symptoms.
Slaton RM, Champion MN, Palmore KB. Slaton RM, et al. J Pharm Pract. 2015 Jun;28(3):266-74. doi: 10.1177/0897190014544785. Epub 2014 Aug 8. J Pharm Pract. 2015. PMID: 25107421 Review.
METHODS: Both PubMed and International Pharmaceutical Abstracts (IPA) were searched using the keywords hot flashes, vasomotor symptoms, menopause, and paroxetine. In PubMed, MeSH terms were used for paroxetine, menopause, and hot flashes. ...CONCLUSION: Paroxetin …
METHODS: Both PubMed and International Pharmaceutical Abstracts (IPA) were searched using the keywords hot flashes, vasomotor symptoms, meno …
Odd odds.
Andrade C. Andrade C. J Clin Psychiatry. 2011 Nov;72(11):1558-9; author reply 1559. doi: 10.4088/JCP.11lr07373. J Clin Psychiatry. 2011. PMID: 22127198 No abstract available.
Paroxetine: safety and tolerability issues.
Marks DM, Park MH, Ham BJ, Han C, Patkar AA, Masand PS, Pae CU. Marks DM, et al. Expert Opin Drug Saf. 2008 Nov;7(6):783-94. doi: 10.1517/14740330802423168. Expert Opin Drug Saf. 2008. PMID: 18983224 Review.
Paroxetine is the most potent inhibitor of serotonin re-uptake among the now available SSRIs. ...Paroxetine and paroxetine CR are not indicated for use in the paediatric population and are categorised as Pregnancy Class D. ...
Paroxetine is the most potent inhibitor of serotonin re-uptake among the now available SSRIs. ...Paroxetine and paroxetine …
Paroxetine-related tremor.
Lai H, Tolat R. Lai H, et al. Geriatrics. 2005 Jul;60(7):18-20. Geriatrics. 2005. PMID: 16026177 Review. No abstract available.
6,788 results